# US 2023/0273189 A1 · Immunoadsorbent and composite affinity column for purifying fumonisins b1, anguidin, t-2 toxin, zearalenone and vomitoxin, method for detecting the same, and preparation method of composite affinity column

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0273189 A1
- Document ID: US20230273189A1
- Status: Published application
- Kind: A1
- Application number: 17/777,056
- Filed: 2020-11-16
- Published: 2023-08-31
- Earliest claimed: 2019-11-15
- Assignees: Oil Crops Research Institute, Chinese Academy of Agricultural Sciences
- Applicants: Oil Crops Research Institute, Chinese Academy of Agricultural Sciences
- Inventors: Qi ZHANG; Yizhen BAI; Nanri YIN; Fei MA; Peiwu LI
- Web page: https://patentgrep.com/patent/US20230273189A1

## CPC

- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/538: by sorbent column, particles or resin strip {, i.e. sorbent materials}
- B01J 20/286: Phases chemically bonded to a substrate, e.g. to silica or to polymers
- B01J 20/3212: {consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds}
- B01J 20/3227: {by end-capping, i.e. with or after the introduction of functional or ligand groups}
- B01J 20/3274: {Proteins, nucleic acids, polysaccharides, antibodies or antigens}
- C07K 16/44: against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids}
- G01N 33/5436: {with ligand physically entrapped within the solid phase (liposomes G01N33/5432; immunological test elements G01N33/54386)}
- G01N 33/56961: {Plant cells or fungi}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 2333/37: from fungi
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

An immunoadsorbent and a composite affinity column for purifying fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin. The immunoadsorbent includes a solid phase carrier, and a fumonisin B1 monoclonal antibody, an anguidin monoclonal antibody, a T-2 toxin monoclonal antibody, a zearalenone monoclonal antibody and a vomitoxin monoclonal antibody which are coupled to the solid phase carrier, the anguidin monoclonal antibody is a monoclonal antibody secreted by a hybridoma cell strain DAS5G11E7 having an accession number of CCTCCNO:C201881. The affinity column can be used for high performance liquid chromatography-mass spectrometry detection of the fumonisin B1, the anguidin, the T-2 toxin, the zearalenone and the vomitoxin, and has stable performance. Furthermore, an economical, quick, precise and safe detection method is established of the basis of the affinity column, and can be used for purifying and detecting samples of the five toxins without mutual interference and influence.

## Claims

### Claim 1

An immunoadsorbent for purifying fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin, the immunoadsorbent comprises a solid phase carrier, and an anti-fumonisin B1 monoclonal antibody, an anti-anguidin monoclonal antibody, an anti-T-2 toxin monoclonal antibody, an anti-zearalenone monoclonal antibody, and an anti-vomitoxin monoclonal antibody which are coupled to the solid phase carrier, and the anti-anguidin monoclonal antibody is a monoclonal antibody secreted by a hybridoma cell strain DAS5G11E7 having an accession number of CCTCCNO:C201881.

### Claim 2 (depends on 1)

The immunoadsorbent according to claim 1, wherein the solid phase carrier is sepharose.

### Claim 3 (depends on 1)

The immunoadsorbent according to claim 1, wherein IC50 of the anti-vomitoxin monoclonal antibody is less than or equal to 15 ppb; IC50 of the anti-T-2 toxin monoclonal antibody is less than or equal to 2 ppb; the anti-fumonisin B1 monoclonal antibody is selected from a monoclonal antibody secreted by a hybridoma cell strain Fm7A11 having an accession number of CCTCC NO.C201636; and the anti-zearalenone monoclonal antibody is selected from a monoclonal antibody secreted by a hybridoma cell strain 2D3 having an accession number of CCTCC NO.C201328.

### Claim 4 (depends on 1)

A composite affinity column for purifying fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin, the composite affinity column being loaded with the immunoadsorbent for purifying fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin according to claim 1.

### Claim 5 (depends on 4)

A preparation method of the composite affinity column according to claim 4, comprising the following steps:
a) matrix treatment
washing CNBr-activated sepharose matrix powder with HCl at a pH of 2-3 to remove impurities;
b) ligand coupling
dissolving a fumonisin B1 monoclonal antibody, an anguidin monoclonal antibody, a T-2 toxin monoclonal antibody, a zearalenone monoclonal antibody, and a vomitoxin monoclonal antibody to be coupled by using a coupling buffer to obtain antibody solutions, quickly transferring the sepharose matrix activated in the step a) to the above antibody solutions, and carrying out coupling;
c) ligand blocking
blocking all remaining active groups;
d) removing excess ligands that are not coupled after the coupling; and
e) packing.

### Claim 6 (depends on 5)

The preparation method of the composite affinity column according to claim 5, wherein the washing is carried out with HCl having a concentration of 1 mmol/L for 15 min in the step a); and the coupling buffer in the step b) is 0.2 mol/L Na2HCO3 with a pH of 8.3.

### Claim 7 (depends on 5)

The preparation method of the composite affinity column according to claim 5, wherein the concentration of each antibody solution in the step b) is 10-15 mg/mL; and
a coupling condition in the step b) comprises: fully mixing the above mixture under a room temperature condition of 20-25° C. for 2-4 h.

### Claim 8 (depends on 5)

The preparation method of the composite affinity column according to claim 5, wherein a process of the ligand blocking in the step c) comprises: transferring the sepharose matrix treated by the step b) to a 0.1 mol/L Tris-HCl buffer, and standing for 2-4h under a room temperature condition.

### Claim 9 (depends on 5)

The preparation method of the composite affinity column according to claim 5, wherein the step d) comprises: successively washing the sepharose matrix treated by the step c) with a buffer solution with a pH value of 4 and a buffer solution with a pH value of 8 for at least three cycles;
wherein the buffer solution with a pH value of 4 and the buffer solution with a pH value of 8 may be respectively selected from 0.1 mol/L acetic acid/sodium acetate buffer and 0.1 mol/L Tris-HCl buffer; and
after treatment in the step d), washing is carried out with 0.01% NaN3-PBS of which the amount is 5 times the volume of the sepharose, preserving is carried out by using 0.01% NaN3-PBS, and then packing is carried out.

### Claim 10 (depends on 4)

A method for detecting the content of fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin based on the composite affinity column of claim 4, comprising adsorbing fumonisin B1, anguidin, T-2 toxin, zearalenone, and vomitoxin by an immunoadsorbent, other impurities flowing out of the composite affinity column when a sample to be detected is allowed to pass through the composite affinity column of claim 4, then eluting the composite affinity column with chromatographic grade methanol, and collecting an eluate for detection in a high performance liquid chromatograph-mass spectrometer to obtain the content of each toxin.
